{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:15:20Z","timestamp":1794118520998,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35NS097263"],"award-info":[{"award-number":["R35NS097263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS123743"],"award-info":[{"award-number":["U54NS123743"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG064690"],"award-info":[{"award-number":["R01AG064690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35NS097273"],"award-info":[{"award-number":["R35NS097273"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01NS084974"],"award-info":[{"award-number":["P01NS084974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41593-025-02049-3","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:04:05Z","timestamp":1761037445000},"page":"2180-2189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["TDP-43 nuclear loss in FTD\/ALS causes widespread alternative polyadenylation changes"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8306-8323","authenticated-orcid":false,"given":"Yi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5895-0259","authenticated-orcid":false,"given":"Anastasiia","family":"Lovchykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-1242","authenticated-orcid":false,"given":"Tetsuya","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-523X","authenticated-orcid":false,"given":"Vidhya","family":"Maheswari Jawahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odilia","family":"Sianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Calliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-4858","authenticated-orcid":false,"given":"Mercedes","family":"Prudencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-1526","authenticated-orcid":false,"given":"Aaron D.","family":"Gitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"2049_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn.2778","volume":"14","author":"JR Tollervey","year":"2011","unstructured":"Tollervey, J. R. et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452\u2013458 (2011).","journal-title":"Nat. Neurosci."},{"key":"2049_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou, M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459\u2013468 (2011).","journal-title":"Nat. Neurosci."},{"key":"2049_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling, S.-C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"2049_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tins.2021.02.008","volume":"44","author":"JR Klim","year":"2021","unstructured":"Klim, J. R., Pintacuda, G., Nash, L. A., Juan, I. G. S. & Eggan, K. Connecting TDP-43 pathology with neuropathy. Trends Neurosci. 44, 424\u2013440 (2021).","journal-title":"Trends Neurosci."},{"key":"2049_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.semcdb.2019.05.023","volume":"99","author":"N Birsa","year":"2020","unstructured":"Birsa, N., Bentham, M. P. & Fratta, P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 99, 193\u2013201 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2049_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling, J. P., Pletnikova, O., Troncoso, J. C. & Wong, P. C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS\u2013FTD. Science 349, 650\u2013655 (2015).","journal-title":"Science"},{"key":"2049_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167\u2013179 (2019).","journal-title":"Nat. Neurosci."},{"key":"2049_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180\u2013190 (2019).","journal-title":"Nat. Neurosci."},{"key":"2049_CR9","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1172\/JCI139741","volume":"130","author":"M Prudencio","year":"2020","unstructured":"Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130, 6080\u20136092 (2020).","journal-title":"J. Clin. Invest."},{"key":"2049_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"A-L Brown","year":"2022","unstructured":"Brown, A.-L. et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131\u2013137 (2022).","journal-title":"Nature"},{"key":"2049_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature 603, 124\u2013130 (2022).","journal-title":"Nature"},{"key":"2049_CR12","doi-asserted-by":"publisher","first-page":"eadg7162","DOI":"10.1126\/scitranslmed.adg7162","volume":"16","author":"S Seddighi","year":"2024","unstructured":"Seddighi, S. et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci. Transl. Med. 16, eadg7162 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2049_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. Nat. Med. 30, 382\u2013393 (2024).","journal-title":"Nat. Med."},{"key":"2049_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00401-023-02599-5","volume":"146","author":"LM Gittings","year":"2023","unstructured":"Gittings, L. M. et al. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS\u2013FTD spectrum. Acta Neuropathol. 146, 433\u2013450 (2023).","journal-title":"Acta Neuropathol."},{"key":"2049_CR15","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379, 1140\u20131149 (2023).","journal-title":"Science"},{"key":"2049_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.818","volume":"12","author":"T Akiyama","year":"2022","unstructured":"Akiyama, T., Koike, Y., Petrucelli, L. & Gitler, A. D. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: towards therapeutic targets and biomarkers. Clin. Transl. Med. 12, e818 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2049_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41580-022-00507-5","volume":"23","author":"S Mitschka","year":"2022","unstructured":"Mitschka, S. & Mayr, C. Context-specific regulation and function of mRNA alternative polyadenylation. Nat. Rev. Mol. Cell Biol. 23, 779\u2013796 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2049_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","volume":"23","author":"LA Passmore","year":"2022","unstructured":"Passmore, L. A. & Coller, J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat. Rev. Mol. Cell Biol. 23, 93\u2013106 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2049_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm.2016.116","volume":"18","author":"B Tian","year":"2017","unstructured":"Tian, B. & Manley, J. L. Alternative polyadenylation of mRNA precursors. Nat. Rev. Mol. Cell Biol. 18, 18\u201330 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2049_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.celrep.2017.04.028","volume":"19","author":"G Rot","year":"2017","unstructured":"Rot, G. et al. High-resolution RNA maps suggest common principles of splicing and polyadenylation regulation by TDP-43. Cell Rep. 19, 1056\u20131067 (2017).","journal-title":"Cell Rep."},{"key":"2049_CR21","doi-asserted-by":"publisher","first-page":"ENEURO.0061-22.","DOI":"10.1523\/ENEURO.0061-22.2022","volume":"9","author":"K Imaizumi","year":"2022","unstructured":"Imaizumi, K., Ideno, H., Sato, T., Morimoto, S. & Okano, H. Pathogenic mutation of TDP-43 impairs RNA processing in a cell type-specific manner: implications for the pathogenesis of ALS\/FTLD. eNeuro 9, ENEURO.0061-22.2022 (2022).","journal-title":"eNeuro"},{"key":"2049_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molcel.2019.03.041","volume":"74","author":"M Modic","year":"2019","unstructured":"Modic, M. et al. Cross-regulation between TDP-43 and paraspeckles promotes pluripotency-differentiation transition. Mol. Cell 74, 951\u2013965 (2019).","journal-title":"Mol. Cell"},{"key":"2049_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala, Y. M. et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277\u2013288 (2011).","journal-title":"EMBO J."},{"key":"2049_CR24","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nn.4065","volume":"18","author":"M Prudencio","year":"2015","unstructured":"Prudencio, M. et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 18, 1175\u20131182 (2015).","journal-title":"Nat. Neurosci."},{"key":"2049_CR25","doi-asserted-by":"publisher","unstructured":"McKeever, P. M. et al. Single-nucleus multiomic atlas of frontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.12.22.573083 (2023).","DOI":"10.1101\/2023.12.22.573083"},{"key":"2049_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu, E. Y. et al. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 27, 1409\u20131421 (2019).","journal-title":"Cell Rep."},{"key":"2049_CR27","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1093\/bioinformatics\/btaa266","volume":"36","author":"R Wang","year":"2020","unstructured":"Wang, R. & Tian, B. APAlyzer: a bioinformatics package for analysis of alternative polyadenylation isoforms. Bioinformatics 36, 3907\u20133909 (2020).","journal-title":"Bioinformatics"},{"key":"2049_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1414-4","volume":"19","author":"KCH Ha","year":"2018","unstructured":"Ha, K. C. H., Blencowe, B. J. & Morris, Q. QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data. Genome Biol. 19, 45 (2018).","journal-title":"Genome Biol."},{"key":"2049_CR29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.stemcr.2020.03.023","volume":"14","author":"R Dafinca","year":"2020","unstructured":"Dafinca, R. et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS\/FTD. Stem Cell Rep. 14, 892\u2013908 (2020).","journal-title":"Stem Cell Rep."},{"key":"2049_CR30","first-page":"D174","volume":"48","author":"CJ Herrmann","year":"2020","unstructured":"Herrmann, C. J. et al. PolyASite 2.0: a consolidated atlas of polyadenylation sites from 3\u2032 end sequencing. Nucleic Acids Res. 48, D174\u2013D179 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2049_CR31","doi-asserted-by":"publisher","first-page":"D315","DOI":"10.1093\/nar\/gkx1000","volume":"46","author":"R Wang","year":"2018","unstructured":"Wang, R., Nambiar, R., Zheng, D. & Tian, B. PolyA_DB 3 catalogs cleavage and polyadenylation sites identified by deep sequencing in multiple genomes. Nucleic Acids Res. 46, D315\u2013D319 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2049_CR32","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.neurobiolaging.2015.06.005","volume":"36","author":"R Ferrari","year":"2015","unstructured":"Ferrari, R. et al. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. Neurobiol. Aging 36, 2904 (2015).","journal-title":"Neurobiol. Aging"},{"key":"2049_CR33","doi-asserted-by":"publisher","unstructured":"Bryce-Smith, S. et al. TDP-43 loss induces extensive cryptic polyadenylation in ALS\/FTD. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-025-02050-w (2025).","DOI":"10.1038\/s41593-025-02050-w"},{"key":"2049_CR34","doi-asserted-by":"publisher","first-page":"D287","DOI":"10.1093\/nar\/gkab702","volume":"50","author":"W Zhao","year":"2022","unstructured":"Zhao, W. et al. POSTAR3: an updated platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 50, D287\u2013D294 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2049_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02799-4","volume":"23","author":"J Linder","year":"2022","unstructured":"Linder, J., Koplik, S. E., Kundaje, A. & Seelig, G. Deciphering the impact of genetic variation on human polyadenylation using APARENT2. Genome Biol. 23, 232 (2022).","journal-title":"Genome Biol."},{"key":"2049_CR36","doi-asserted-by":"publisher","first-page":"e182088","DOI":"10.1172\/JCI182088","volume":"135","author":"FJ Arnold","year":"2025","unstructured":"Arnold, F. J. et al. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia. J. Clin. Invest. 135, e182088 (2025).","journal-title":"J. Clin. Invest."},{"key":"2049_CR37","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/JNEUROSCI.0543-14.2014","volume":"34","author":"MD Figley","year":"2014","unstructured":"Figley, M. D., Bieri, G., Kolaitis, R.-M., Taylor, J. P. & Gitler, A. D. Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J. Neurosci. 34, 8083\u20138097 (2014).","journal-title":"J. Neurosci."},{"key":"2049_CR38","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/hmg\/ddy043","volume":"27","author":"A Bento-Abreu","year":"2018","unstructured":"Bento-Abreu, A. et al. Elongator subunit 3 (ELP3) modifies ALS through tRNA modification. Hum. Mol. Genet. 27, 1276\u20131289 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"2049_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/hmg\/ddn375","volume":"18","author":"CL Simpson","year":"2009","unstructured":"Simpson, C. L. et al. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum. Mol. Genet. 18, 472\u2013481 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"2049_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.105","volume":"1305","author":"K Volkening","year":"2009","unstructured":"Volkening, K., Leystra-Lantz, C., Yang, W., Jaffee, H. & Strong, M. J. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper\/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res. 1305, 168\u2013182 (2009).","journal-title":"Brain Res."},{"key":"2049_CR41","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani, L. et al. Neurofilament light chain as a biomarker in neurological disorders. J. Neurol. Neurosurg. Psychiatry 90, 870\u2013881 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2049_CR42","doi-asserted-by":"publisher","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","volume":"96","author":"JC Rojas","year":"2021","unstructured":"Rojas, J. C. et al. Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration. Neurology 96, e2296\u2013e2312 (2021).","journal-title":"Neurology"},{"key":"2049_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","volume":"35","author":"MJ Strong","year":"2007","unstructured":"Strong, M. J. et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35, 320\u2013327 (2007).","journal-title":"Mol. Cell. Neurosci."},{"key":"2049_CR44","doi-asserted-by":"publisher","first-page":"e85653","DOI":"10.1371\/journal.pone.0085653","volume":"9","author":"M Ishtiaq","year":"2014","unstructured":"Ishtiaq, M., Campos-Melo, D., Volkening, K. & Strong, M. J. Analysis of novel NEFL mRNA targeting microRNAs in amyotrophic lateral sclerosis. PLoS ONE 9, e85653 (2014).","journal-title":"PLoS ONE"},{"key":"2049_CR45","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.3390\/ijms21197151","volume":"21","author":"YW Lim","year":"2020","unstructured":"Lim, Y. W., James, D., Huang, J. & Lee, M. The emerging role of the RNA-binding protein SFPQ in neuronal function and neurodegeneration. Int. J. Mol. Sci. 21, 7151 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2049_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22098-z","volume":"12","author":"PM Gordon","year":"2021","unstructured":"Gordon, P. M., Hamid, F., Makeyev, E. V. & Houart, C. A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons. Nat. Commun. 12, 1918 (2021).","journal-title":"Nat. Commun."},{"key":"2049_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04373-8","volume":"9","author":"R Luisier","year":"2018","unstructured":"Luisier, R. et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 9, 2010 (2018).","journal-title":"Nat. Commun."},{"key":"2049_CR48","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.celrep.2017.01.013","volume":"18","author":"S Ishigaki","year":"2017","unstructured":"Ishigaki, S. et al. Altered tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes. Cell Rep. 18, 1118\u20131131 (2017).","journal-title":"Cell Rep."},{"key":"2049_CR49","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/brain\/awaa196","volume":"143","author":"S Ishigaki","year":"2020","unstructured":"Ishigaki, S. et al. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases. Brain 143, 2398\u20132405 (2020).","journal-title":"Brain"},{"key":"2049_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234\u2013239 (2010).","journal-title":"Nat. Genet."},{"key":"2049_CR51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185, 1346\u20131355 (2022).","journal-title":"Cell"},{"key":"2049_CR52","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang, Y. X. et al. Amyloid fibrils in disease FTLD-TDP are composed of TMEM106B not TDP-43. Nature 605, 304\u2013309 (2022).","journal-title":"Nature"},{"key":"2049_CR53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310\u2013314 (2022).","journal-title":"Nature"},{"key":"2049_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-022-00665-3","volume":"32","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. Generic amyloid fibrillation of TMEM106B in patient with Parkinson\u2019s disease dementia and normal elders. Cell Res. 32, 585\u2013588 (2022).","journal-title":"Cell Res."},{"key":"2049_CR55","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin, A. S. et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J. Neurosci. 32, 11213\u201311227 (2012).","journal-title":"J. Neurosci."},{"key":"2049_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41511-3","volume":"14","author":"M Malnar \u010crnigoj","year":"2023","unstructured":"Malnar \u010crnigoj, M. et al. Phenylalanine-tRNA aminoacylation is compromised by ALS\/FTD-associated C9orf72 C4G2 repeat RNA. Nat. Commun. 14, 5764 (2023).","journal-title":"Nat. Commun."},{"key":"2049_CR57","doi-asserted-by":"publisher","first-page":"e090857","DOI":"10.1002\/alz.090857","volume":"20","author":"AN Salazar","year":"2024","unstructured":"Salazar, A. N. et al. An AluYb8 mobile element characterises the risk haplotype of the TMEM106B locus associated with neurodegeneration. Alzheimers Dement. 20, e090857 (2024).","journal-title":"Alzheimers Dement."},{"key":"2049_CR58","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1002\/alz.14090","volume":"20","author":"A Rodney","year":"2024","unstructured":"Rodney, A., Karanjeet, K., Benzow, K. & Koob, M. D. A common Alu insertion in the 3\u2032UTR of TMEM106B is associated with risk of dementia. Alzheimers Dement. 20, 5071\u20135077 (2024).","journal-title":"Alzheimers Dement."},{"key":"2049_CR59","doi-asserted-by":"publisher","first-page":"e200124","DOI":"10.1212\/NXG.0000000000200124","volume":"10","author":"A Chemparathy","year":"2024","unstructured":"Chemparathy, A. et al. A 3\u2032UTR insertion is a candidate causal variant at the TMEM106B locus associated with increased risk for FTLD-TDP. Neurol. Genet. 10, e200124 (2024).","journal-title":"Neurol. Genet."},{"key":"2049_CR60","doi-asserted-by":"publisher","first-page":"eadf9735","DOI":"10.1126\/scitranslmed.adf9735","volume":"16","author":"JD Marks","year":"2024","unstructured":"Marks, J. D. et al. TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia. Sci. Transl. Med. 16, eadf9735 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2049_CR61","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","volume":"137","author":"G Bieri","year":"2019","unstructured":"Bieri, G. et al. LRRK2 modifies \u03b1-syn pathology and spread in mouse models and human neurons. Acta Neuropathol. 137, 961\u2013980 (2019).","journal-title":"Acta Neuropathol."},{"key":"2049_CR62","doi-asserted-by":"publisher","unstructured":"\u00c7elik, M. H. & Mortazavi, A. Analysis of alternative polyadenylation from long-read or short-read RNA-seq with LAPA. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.11.08.515683 (2022).","DOI":"10.1101\/2022.11.08.515683"},{"key":"2049_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-023-00646-z","volume":"18","author":"V Estades Ayuso","year":"2023","unstructured":"Estades Ayuso, V. et al. TDP-43-regulated cryptic RNAs accumulate in Alzheimer\u2019s disease brains. Mol. Neurodegener. 18, 57 (2023).","journal-title":"Mol. Neurodegener."},{"key":"2049_CR64","doi-asserted-by":"publisher","unstructured":"Zeng, Y. & Gitler, A. TDP-43 nuclear loss in FTD\/ALS causes widespread alternative polyadenylation changes (version V2). Zenodo https:\/\/doi.org\/10.5281\/zenodo.15637268 (2025).","DOI":"10.5281\/zenodo.15637268"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02049-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:59:19Z","timestamp":1775033959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02049-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02049-3","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.G. is a scientific founder of Maze Therapeutics, Trace Neuroscience and Lyterian Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}